News

The Manila Times2d
Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results
In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of ...
BioPharma Dive2d
Gilead, bracing for tariffs, joins peers in US drug production push
The company added to a recent flurry of pledges by pharmaceutical companies, promising $11 billion in new capital and ...
OpenAI and the FDA are reportedly discussing AI for drug evaluations
OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...
OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation
High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...
Kauppalehti5d
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
Two biosimilars developed under the Teva - Alvotech partnership have been granted FDA approval with interchangeability, including SELARSDI. In February 2024, the FDA approved SIMLANDI® ...